In the News

Outside Media Coverage of Dr. Sartor’s Research

Dr. Sartor Talks About the Tulane Cancer Center Prostate Cancer Research Program—YouTube, April 2014
Dr. Sartor Discusses Custirsen as Treatment for Prostate Cancer—Targeted Oncology, April 10, 2014
Dr. Sartor on Provenge in Combination with Radium-223—OncLiveTV, April 1, 2014
Dr. Sartor Discusses PSA Testing Guidelines—Targeted Oncology, March 27, 2014
Dr. Sartor Discusses PSA Testing for Prostate Cancer—OncLiveTV, March 17, 2014
Decade of Wisdom: A. Oliver Sartor, M.D.— 2014 Genitourinary Cancers Symposium, January 31, 2014
An Update on New Therapies for mCRPC: An Interview with Oliver Sartor M.D.—Renal & Urology News, September 13, 2013
Dr. Sartor on Progress for the Treatment of Prostate Cancer—OncLiveTV, September 3, 2013
Dr. Sartor on the Mechanism of Action of Radium-223—OncLiveTV, July 9, 2013—June 28, 2013
Dr. Sartor on Recent Progress on the Molecular Front for the Treatment of Prostate Cancer—Targeted Oncology, June 26, 2013
Surveillance for Prostate Cancer: Are the Proceduralists Running Amok? – Cancer Network, June 11, 2013
New Hope in the Battle Against Prostate Cancer –, May 28, 28, 2013
Should Men Get PSA Tests to Screen for Prostate Cancer? – Wall Street Journal – February 14, 2013
Dr. Oliver Sartor Discusses PSA Screening – OncLiveTV, May 22, 2012
Dr. Oliver Sartor Discusses a New Prostate Cancer Trial Combining Radium-223 and Provenge—OncLiveTV, April 12, 2012
Dr. Oliver Sartor Discusses Radium-223 in Early Prostate Cancer—OncLiveTV, April 4, 2012
Thought Leader Conversations with A. Oliver Sartor, M.D.—Institute for Medical Education & Research (IMER), February 13, 2012
Experimental Drugs Do Battle Against Advanced Prostate Cancer—U.S. News & World Report, February 1, 2012
Dr. Sartor on Patients in the ALSYMPCA Radium-223 Trial—OncLiveTV, December 20, 2011
Dr. Sartor Discusses Prostate Cancer Drug Combinations—OncLiveTV, November 29, 2011
Dr. Sartor Discusses the Novel Agent Radium-223—OncLiveTV, November 15, 2011
Taxanes: Pivotal Agents in the Management of Metastatic Castration-Resistant Prostate Cancer, June 2, 2011
Cancer Experts Brand Lockerbie Bomber Release “Ridiculous” – The Telegraph, September 2010
United States Senate Committee on Foreign Relations – Testimony of Dr. Oliver Sartor, September 29, 2010
Searching For a Miracle Cure (Oliver Sartor, MD) – New Orleans Magazine, August 2010
Jevtana (cabazitaxel) Injection Approved by U.S. FDA After Priority Review—GoodNews Broadcast, July 23, 2010
Drugs Help Men With Advanced Prostate Cancer – WWL-TV Channel 6, July 6, 2010
Men Have Hormones Too – Men’s Health, May 5, 2010
Positive Test for Sanofi Prostate Cancer Drug – New York Times, March 3, 2010
Leading Study Backs Hormone Therapy With Radiation for Recurrent Prostate Cancer – Tulane University New Wave – February 2017
Dr. Oliver Sartor on Considerations, Controversy With PSA Testing in Prostate Cancer – Targeted Oncology – May 2016
Popular Prostate Cancer Therapy May be Harmful – Medical XPress – October 2014


Tulane Cancer Center Newsletter Coverage of Dr. Sartor’s Research

Tulane Major Player in FDA Approval of New Drug for Advanced Prostate Cancer—Spring 2013 Issue
Perez Family Honors Father by Raising $104,000 for Prostate Cancer Research—Spring 2013 Issue
Sporting Clays Event Targets Prostate Cancer Research/Awareness—Fall 2012 Issue
Deciphering New PSA Screening Guidelines: What’s a Fellow to Do? – June 2012 Issue
New Prostate Cancer Treatment Vaccine Available at Tulane—May 2011 Issue
Educational Symposium on Prostate Cancer Open to the Public—May 2011
Sporting Clays Fundraiser to Benefit Prostate Cancer Research Efforts of Oliver Sartor, M.D.—June 2011 Issue
One Man Can Make a Difference—August 2011 Issue
Oliver Sartor Named Medical Director—August 2010 Issue
FDA Approves New Drug for Advanced Prostate Cancer Patients—August 2010 Issue
Complimentary Prostate Cancer Screenings—January 2009 Issue


Tulane University New Wave Coverage of Dr. Sartor’s Research

Popular Prostate Cancer Therapy May be Harmful – New Wave, October 22, 2014
Family Honors Father by Raising $104,000 for Prostate Cancer Research – June 13, 2013
Tulane Major Player in FDA Approval of New Drug for Advanced Prostate Cancer – May 28, 2013
Event Targets Prostate Cancer Awareness – September 23, 2011
Drug May Extend Life for Prostate Cancer Patients – March 4, 2010
Halting Men’s Most Common Cancer – November 24, 2009
Raising Awareness About Prostate Cancer – September 12, 2008
Free Cancer Screenings Help Men Take Charge of Their Health – April 2, 2008
Major Player Joins Prostate Cancer Team – March 14, 2008